Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 305661 - 305680 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Lebanon | (L01FB01) inotuzumab ozogamicin | BESPONSA FOR INJECTION 0.9mg/Vial | Pack of 1Vial, powder for suspension for intravenous infusion only, 0.9mg/Vial, 0.9mg/Vial , powder for suspension for intravenous infusion only | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | Pharmacia&UpjohnCompanyLLC / DroguerieFattalS.A.L. |
| Lebanon | (L01FD01) trastuzumab | MABTIN 440 440mg | 1Vial of trastuzumab for injection + 1Vial of bacteriostatic water for injection (multi-dose), Lyophilized powder for IV infusion, 440mg, 440mg , Lyophilized powder for IV infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | BioconBiologicsLimited,India,forBentaSAL / BentaTradingCos.a.l. |
| Lebanon | (L01FD01) trastuzumab | TRASTUREL 440mg | box of 1, Lyophilized powder for injection, 440mg, 440mg , Lyophilized powder for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | RelianceLifeSciencespvtLtd / LevantPulseSARL |
| Lebanon | (L01FD01) trastuzumab | TRAZIMERA 150mg/vial | 1Vial, Intravenous infusion, 150mg/vial, 150mg/vial , Intravenous infusion | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerManufacturingBelgiumNV / DroguerieFattalS.A.L. |
| Lebanon | (L01FD01) trastuzumab | KANJINTI 420mg | 1Vial, Powder for concentrate for solution for infusion, 420mg, 420mg , Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AmgenEuropeBV / Mersaco |
| Lebanon | (L01FD01) trastuzumab | TRAZIMERA 440mg/vial | 1Vial + 1Vial of solvent, Intravenous infusion, 440mg/vial, 440mg/vial , Intravenous infusion | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerManufacturingBelgiumNV / DroguerieFattalS.A.L. |
| Lebanon | (L01FD02) pertuzumab | PERJETA 420MG 420mg/14ml | 1 Vial, Injectable concentrate for solution for infusion, 420mg/14ml, 420mg/14ml , Injectable concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheDiagnosticsGmbH / Omnipharma |
| Lebanon | (L01FD03) trastuzumab emtansine | KADCYLA 100mg | 1Vial, Injectable powder for concentrate for solution for infusion, 100mg, 100mg , Injectable powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | F.HoffmannLaRocheLtd,Kaiseraugst / Omnipharma |
| Lebanon | (L01FD03) trastuzumab emtansine | KADCYLA 160mg | 1Vial, Injectable powder for concentrate for solution for infusion, 160mg, 160mg , Injectable powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | F.HoffmannLaRocheLtd,Kaiseraugst / Omnipharma |
| Lebanon | (L01FE02) panitumumab | VECTIBIX 20mg/ml | 1Vial x 20ml, Concentrate for solution for infusion, 20mg/ml, 20mg/ml , Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeBV / Mersaco |
| Lebanon | (L01FE02) panitumumab | VECTIBIX 20mg/ml | 1Vial x 5ml, Concentrate for solution for infusion, 20mg/ml, 20mg/ml , Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeBV / Mersaco |
| Lebanon | (L01FF01) nivolumab | OPDIVO 100mg/10ml | 1Vial, Injection, 100mg/10ml, 100mg/10ml , Injection | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbHoldingsPharmaLtdLiabilityCompanyManati / Pacificpharma |
| Lebanon | (L01FF01) nivolumab | OPDIVO 40mg/4ml | 1Vial, Injection, 40mg/4ml, 40mg/4ml , Injection | Retail price without vat |
$0-0 |
$0-0 |
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Carcinoma, Transitional Cell;Squamous Cell Carcinoma of Head and Neck;Urologic Neoplasms;Mesothelioma;Colorectal Neoplasms | Bristol-MyersSquibbHoldingsPharmaLtdLiabilityCompanyManati / Pacificpharma |
| Lebanon | (L01FF03) durvalumab | IMFINZI 120mg/2.4ml (50mg/ml) | 1Vial, Injection, 120mg/2.4ml (50mg/ml), 120mg/2.4ml (50mg/ml) , Injection | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | CatalentIndiana,LLC / Omnipharma |
| Lebanon | (L01FF03) durvalumab | IMFINZI 120mg/2.4ml (50mg/ml) | 1Vial, Injection, 120mg/2.4ml (50mg/ml), 120mg/2.4ml (50mg/ml) , Injection | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB / Omnipharma |
| Lebanon | (L01FF03) durvalumab | IMFINZI 500mg/10ml (50mg/ml) | 1Vial, Injection, 500mg/10ml (50mg/ml), 500mg/10ml (50mg/ml) , Injection | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | CatalentIndiana,LLC / Omnipharma |
| Lebanon | (L01FF03) durvalumab | IMFINZI 500mg/10ml (50mg/ml) | 1Vial, Injection, 500mg/10ml (50mg/ml), 500mg/10ml (50mg/ml) , Injection | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB / Omnipharma |
| Lebanon | (L01FG01) bevacizumab | BEVACIREL 100mg/4ml | 1Vial, injection for intravenous infusion, 100mg/4ml, 100mg/4ml , injection for intravenous infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | RelianceLifeSciencespvtLtd / LevantPulseSARL |
| Lebanon | (L01FG01) bevacizumab | MVASI 25mg/ml (100mg) | 1Vialx4ml, Concentrate for solution for infusion, 25mg/ml (100mg), 25mg/ml (100mg) , Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AmgenManufacturingLtd / Mersaco |
| Lebanon | (L01FG01) bevacizumab | MVASI 25mg/ml (400mg) | 1Vialx16ml, Concentrate for solution for infusion, 25mg/ml (400mg), 25mg/ml (400mg) , Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AmgenManufacturingLtd / Mersaco |
Pages
